Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1511 (LINC01511)

Target
LINC01511
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

Long intergenic non-protein coding RNA 1511 (LINC01511) is a long non-coding RNA (lncRNA) gene transcribed in humans, belonging to the class of intergenic lncRNAs[1][6][5]. LINC01511 is located at chromosome 21q22 and is expressed in various tissues, with distinct upregulation noted in antigen-experienced T cells, suggesting a possible function in immune memory and T cell activity[6]. While its precise biological role is not well established, it is believed to participate in the regulation of transcription and other epigenetic processes, as is typical for lincRNAs[5][7]. Emerging data suggest that LINC01511 may be associated with cancer development and progression, but mechanistic evidence is currently lacking and it is not considered a validated therapeutic target[5]. No known drugs target LINC01511, and there is no recognized use as a biomarker for patient selection or therapy monitoring in clinical settings. Additional research is required to define its full biological significance and clinical relevance[1][5][6][7].

Other names
RP11-325I22.2LINC01511Non-protein coding RNA 1511ENSG00000250584NCBI GeneID: 100506791
02

Biological functions

Putatively involved in immune system regulation, particularly in antigen-experienced T cells and immunological memory.Potential role in gene regulation and modulation of transcription, as is typical for many lincRNAs.Exact functions are not well established and require further research.
03

Disease associations

Other — There is emerging but unconfirmed evidence for involvement in cancer development and progression.May be implicated in immune system function, as suggested by expression in T cells.
04

Safety considerations

Not applicable; LINC01511 itself is not targeted by existing therapeutics, so no direct safety concerns have been reported.
05

Biomarkers

No established biomarker use; possible investigational biomarker for immune cell function or cancer, but not confirmed in clinical practice.

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1511 (LINC01511).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1511 (LINC01511).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call